Duke Cancer Institute

Duke study identifies biomarkers that could predict immunotherapy resistance in melanoma

Posted by WRAL TechWire | Nov 25, 2022

Duke Cancer Institute researchers have identified potential biomarkers that predict the likelihood for checkpoint inhibitor drugs to backfire, driving hyper-progression of melanoma cells instead of unleashing the immune system to fight them.

Duke researchers discover possible breakthrough therapy for those with advanced prostate cancer

Posted by WRAL News | Dec 4, 2019

The researchers identified a cell surface receptor that is essential for the function and survival of resistant prostate cancer cells, and showed in laboratory studies that this receptor can be targeted to halt tumor growth.